| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 116.00× | 116.00× | 92.63× | 73.65× | 93.41× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.87× | 0.82× | 1.31× | 1.48× | 1.05× | ||
| 0.36× | 0.36× | 0.41× | 0.52× | 0.37× | ||
| −1.12× | −1.12× | −1.81× | −1.13× | 4.39× | ||
| −0.67× | −0.67× | −1.03× | −0.68× | 2.67× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 93.41 | 73.65 | 92.63 | 116.00 | 116.00 | |
| Working Capital Turnover | 1.05 | 1.48 | 1.31 | 0.82 | 0.87 | |
| Asset Turnover | 0.37 | 0.52 | 0.41 | 0.36 | 0.36 | |
| Cash Conversion (CFO/Net Income) | 4.39 | -1.13 | -1.81 | -1.12 | -1.12 | |
| CFO/EBITDA | 2.67 | -0.68 | -1.03 | -0.67 | -0.67 |